- Filed
- Nov 13, 2020 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2021 · Nov 13, 2020 | 13.55M sh |
| Shares Diluted | Q2 2021 · Sep 30, 2020 | 13.55M sh |
| Shares Diluted | Q2 2021 · Sep 30, 2020 | 12.6M sh |
| Shares Diluted | Q2 2021 · Sep 30, 2019 | 7.26M sh |
| Shares Diluted | Q2 2021 · Sep 30, 2019 | 7.22M sh |
| Current Liabilities | Q2 2021 · Sep 30, 2020 | $743.38K |
| Current Liabilities | Q2 2021 · Mar 31, 2020 | $1.23M |
| Total Liabilities | Q2 2021 · Sep 30, 2020 | $1.09M |
| Total Liabilities | Q2 2021 · Mar 31, 2020 | $1.73M |
| Current Assets | Q2 2021 · Sep 30, 2020 | $773.22K |
| Current Assets | Q2 2021 · Mar 31, 2020 | $175.84K |
| Total Assets | Q2 2021 · Sep 30, 2020 | $2.35M |
| Total Assets | Q2 2021 · Mar 31, 2020 | $1.64M |
| Capex | Q2 2021 · Sep 30, 2019 | $428 |
| Operating Cash Flow | Q2 2021 · Sep 30, 2019 | −$328.48K |
| Stockholders Equity | Q2 2021 · Sep 30, 2019 | $389.33K |
| Stockholders Equity | Q2 2021 · Jun 30, 2019 | $335.31K |
| Stockholders Equity | Q2 2021 · Mar 31, 2019 | $440.2K |
| Sga Expense restated | Q2 2021 · Sep 30, 2019 | $54.83K |
| Sga Expense restated | Q2 2021 · Sep 30, 2019 | $143.4K |
| Rd Expense | Q2 2021 · Sep 30, 2019 | $9.77K |
| Net Income | Q2 2021 · Sep 30, 2019 | −$344.76K |
| Net Income | Q2 2021 · Sep 30, 2019 | −$700.15K |
| Net Income | Q2 2021 · Jun 30, 2019 | −$355.4K |
| Operating Income | Q2 2021 · Sep 30, 2019 | −$294.95K |
| Operating Income | Q2 2021 · Sep 30, 2019 | −$596.5K |